Women with dense breast tissue will be given additional information at their cancer screenings - including guidance that their tests are harder to interpret and suggest they speak with their doctors about more testing.
Women with dense breast tissue will be given additional information at their cancer screenings under new rules adopted by the FDA.
Providers of mammograms will have to tell women that their tests are harder to interpret and suggest they speak with their doctors about more testing,Breast cancer is the second most common cancer in American women, after skin cancers, says the. This year, about 300,000 new cases will be diagnosed, and about 43,700 women will die from breast cancer, the organization says.
“Today’s action represents the agency’s broader commitment to support innovation to prevent, detect and treat cancer,” Hilary Marston, the FDA’s chief medical officer, said. Most states require that women be told when their mammogram finds they have dense breasts. The FDA decision applies a minimum standard for 8,700 facilities across the country, and states can still require more explicit wording,“Dense breasts have relatively less fatty tissue and higher amounts of glandular and fibrous connective tissue,” The Post wrote. “Nearly half of all women 40 and over have the condition.
Mammogram providers have 18 months to comply with the standards. Information about dense breasts will be included in a letter to patients and their physicians.American Cancer Society: “Key Statistics for Breast Cancer.”© 2023 WebMD, LLC. All rights reserved.
México Últimas Noticias, México Titulares
Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.
FDA sets national mammogram standards to protect women with dense breastsMammogram providers will be required to inform women with dense breast tissue that their cancer screenings may be difficult to interpret and recommend consulting their doctors about the need for additional tests, the Food and Drug Administration announced.
Leer más »
FDA says mammogram facilities must notify women if they have dense breast tissueIn a major effort to improve breast cancer prevention, the FDA will now require mammogram facilities to inform women if they have dense breast tissue.
Leer más »
Mammogram results must let women know about their breast density, FDA mandatesMore than half of women over 40 in the U.S. have dense breasts, which affects how their breast tissue shows up on a mammogram.
Leer más »
Doctor talks about new FDA-approved blood test for diagnosing concussionsThe FDA has cleared a blood test to diagnosis a concussion, which is big deal for doctors and patients.
Leer más »
FDA's New Mammogram Guidelines Could Help Detect Breast Cancer EarlierAll U.S. women getting mammograms will soon receive information about their breast density, which can sometimes make cancer harder to spot.
Leer más »
Medical practitioners will have to notify patients about breast density in mammograms under new FDA regulationsThis is the first nationwide ruling that says physicians must notify patients about their breast density. People with dense breasts are more likely to develop breast cancer, even as dense breast tissue makes it harder to detect cancer.
Leer más »